Results 231 to 240 of about 71,170 (384)

European Guideline (EuroGuiDerm) on atopic eczema: Living update

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
The updated guideline includes a new evidence‐based recommendation for the IL‐13 inhibitor lebrikizumab. In addition, the Janus kinase inhibitors baricitinib and abrocitinib, which were initially only approved for adult patients, are now also recommended for children from the age of 2 and adolescents from the age of 12, respectively.
A. Wollenberg   +31 more
wiley   +1 more source

Allergic rhinitis and urticaria burden and antihistamine treatment options in Thailand: A modified Delphi study. [PDF]

open access: yesJ Allergy Clin Immunol Glob
Chantaphakul H   +9 more
europepmc   +1 more source

Allergic rhinitis [PDF]

open access: yes, 2017
Choices Allergic Rhinitis   +1 more
core   +1 more source

ANTIHISTAMINE DRUGS IN PRE-ANAESTHETIC MEDICATION: BLIND STUDIES ON 953 PATIENTS

open access: bronze, 1960
Erwin Lear   +5 more
openalex   +1 more source

Prevalence, treatment and burden of chronic spontaneous urticaria in five European countries

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
This study evaluates prevalence, treatment patterns, disease profile and burden in patients with chronic spontaneous urticaria (CSU) in five European countries (EU5: France, Germany, Italy, Spain and the United Kingdom [UK]). CU, chronic urticaria; ER, emergency room; GAD, General Anxiety Disorder‐7; HRU, healthcare resource use; HRQoL, health‐related ...
Maria‐Magdalena Balp   +8 more
wiley   +1 more source

Comparative Safety of Medications for Severe Agitation: A Geriatric Emergency Department Guidelines 2.0 Systematic Review

open access: yesJournal of the American Geriatrics Society, EarlyView.
ABSTRACT Background Managing undifferentiated, severe agitation in older adults may require antipsychotic or sedative medications to prevent harm to self or others. Unfortunately, these medications are associated with serious adverse events in older adults, and little is known about their comparative safety.
Martin F. Casey   +21 more
wiley   +1 more source

Home - About - Disclaimer - Privacy